↓ Skip to main content

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial

Overview of attention for article published in this source, January 2022
Altmetric Badge

Mentioned by

news
2 news outlets

Readers on

mendeley
30 Mendeley